277 related articles for article (PubMed ID: 28161382)
1. Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus.
Shehata MM; Kamal MM; El-Hefnawy MH; El-Mesallamy HO
J Diabetes Complications; 2017 Apr; 31(4):748-752. PubMed ID: 28161382
[TBL] [Abstract][Full Text] [Related]
2. Serum Vitamin D and Its Upregulated Protein, Thioredoxin Interacting Protein, Are Associated With Beta-Cell Dysfunction in Adult Patients With Type 1 and Type 2 Diabetes.
Omar DF; Kamal MM; El-Hefnawy MH; El-Mesallamy HO
Can J Diabetes; 2018 Dec; 42(6):588-594. PubMed ID: 29980378
[TBL] [Abstract][Full Text] [Related]
3. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
Wegner M; Winiarska H; Bobkiewicz-Kozłowska T; Dworacka M
Cytokine; 2008 Jun; 42(3):312-6. PubMed ID: 18397831
[TBL] [Abstract][Full Text] [Related]
4. Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic β cells and liver.
Wang C; Burkhardt BR; Guan Y; Yang J
Nutr Rev; 2012 Feb; 70(2):100-6. PubMed ID: 22300596
[TBL] [Abstract][Full Text] [Related]
5. Neonatal and infant beta cell hormone concentrations in relation to type 1 diabetes risk.
Stumpp C; Beyerlein A; Ziegler AG; Bonifacio E
Pediatr Diabetes; 2014 Nov; 15(7):528-33. PubMed ID: 24552441
[TBL] [Abstract][Full Text] [Related]
6. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Festa A; Williams K; Hanley AJ; Haffner SM
Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
[TBL] [Abstract][Full Text] [Related]
7. Serum bilirubin concentrations are positively associated with serum C-peptide levels in patients with Type 2 diabetes.
Chung JO; Cho DH; Chung DJ; Chung MY
Diabet Med; 2014 Nov; 31(11):1316-22. PubMed ID: 24910105
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
Van Dalem A; Demeester S; Balti EV; Keymeulen B; Gillard P; Lapauw B; De Block C; Abrams P; Weber E; Vermeulen I; De Pauw P; Pipeleers D; Weets I; Gorus FK;
PLoS One; 2016; 11(12):e0166702. PubMed ID: 27907006
[TBL] [Abstract][Full Text] [Related]
9. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.
Hanley AJ; Retnakaran R; Qi Y; Gerstein HC; Perkins B; Raboud J; Harris SB; Zinman B
J Clin Endocrinol Metab; 2009 Oct; 94(10):3824-32. PubMed ID: 19622625
[TBL] [Abstract][Full Text] [Related]
10. Proinsulin/insulin ratio as a predictor of insulin resistance and B-cell dysfunction in obese Egyptians ((insulin resistance & B-cell dysfunction in obese Egyptians)).
El Shabrawy AM; Elbana KA; Abdelsalam NM
Diabetes Metab Syndr; 2019; 13(3):2094-2096. PubMed ID: 31235142
[TBL] [Abstract][Full Text] [Related]
11. Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic beta-cell area.
Breuer TG; Menge BA; Banasch M; Uhl W; Tannapfel A; Schmidt WE; Nauck MA; Meier JJ
Eur J Endocrinol; 2010 Oct; 163(4):551-8. PubMed ID: 20679359
[TBL] [Abstract][Full Text] [Related]
12. Serum insulin, proinsulin and proinsulin/insulin ratio in type 2 diabetic patients: as an index of beta-cell function or insulin resistance.
Kim NH; Kim DL; Choi KM; Baik SH; Choi DS
Korean J Intern Med; 2000 Dec; 15(3):195-201. PubMed ID: 11242807
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function.
Robert-Cooperman CE; Carnegie JR; Wilson CG; Yang J; Cook JR; Wu J; Young RA; Wolf BA; Burkhardt BR
Diabetes; 2010 Sep; 59(9):2209-18. PubMed ID: 20566664
[TBL] [Abstract][Full Text] [Related]
14. PANDER transgenic mice display fasting hyperglycemia and hepatic insulin resistance.
Robert-Cooperman CE; Dougan GC; Moak SL; Athanason MG; Kuehl MN; Bell-Temin H; Stevens SM; Burkhardt BR
J Endocrinol; 2014 Mar; 220(3):219-31. PubMed ID: 24468680
[TBL] [Abstract][Full Text] [Related]
15. Increased pancreatic-derived factor (PANDER) levels in gestational diabetes mellitus.
Koroglu N; Temel Yuksel I; Aslan Cetin B; Nur Tola E; Fitnat Topbas N; Turhan U; Yetkin Yildirim G
Gynecol Endocrinol; 2019 Oct; 35(10):866-868. PubMed ID: 30982368
[TBL] [Abstract][Full Text] [Related]
16. Limitations of the fasting proinsulin to insulin ratio as a measure of β-cell health in people with and without impaired glucose tolerance.
Egan AM; Laurenti MC; Hurtado Andrade MD; Dalla Man C; Cobelli C; Bailey KR; Vella A
Eur J Clin Invest; 2021 Jun; 51(6):e13469. PubMed ID: 33289929
[TBL] [Abstract][Full Text] [Related]
17. Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes.
Kumar H; Mishra M; Bajpai S; Pokhria D; Arya AK; Singh RK; Tripathi K
Acta Diabetol; 2013 Aug; 50(4):511-8. PubMed ID: 21695404
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells.
Yang J; Robert CE; Burkhardt BR; Young RA; Wu J; Gao Z; Wolf BA
Diabetes; 2005 Nov; 54(11):3217-28. PubMed ID: 16249448
[TBL] [Abstract][Full Text] [Related]
19. Structure-function studies of PANDER, an islet specific cytokine inducing cell death of insulin-secreting beta cells.
Yang J; Gao Z; Robert CE; Burkhardt BR; Gaweska H; Wagner A; Wu J; Greene SR; Young RA; Wolf BA
Biochemistry; 2005 Aug; 44(34):11342-52. PubMed ID: 16114871
[TBL] [Abstract][Full Text] [Related]
20. Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).
Loopstra-Masters RC; Haffner SM; Lorenzo C; Wagenknecht LE; Hanley AJ
Diabetologia; 2011 Dec; 54(12):3047-54. PubMed ID: 21959959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
